Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greenhalgh

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Molecular Carcinogenesis|June 13, 2024
14-3-3σ/Stratifin and p21 limit AKT-related malignant progression in skin carcinogenesis following MDM2-associated p53 lossCarol M McMenemy, Dajiang Guo, Jean A Quinn, et al.
The Journal of Biological Chemistry|September 25, 1993
Hydrophobic amino acids in the retinal-binding pocket of bacteriorhodopsinD A Greenhalgh, D L Farrens, S Subramaniam, et al.
Carcinogenesis|January 8, 2020
Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papillomaSiti F Masre, Nicola Rath, Michael F Olson, et al.
Oncogene|September 17, 2013
PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibitionF H Macdonald, D Yao, J A Quinn, et al.
Oncogene|December 20, 2016
ROCK2/ras<sup>Ha</sup> co-operation induces malignant conversion via p53 loss, elevated NF-κB and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-κB-mediated progressionS F Masre, N Rath, M F Olson, et al.
Cancer Research|October 1, 1996
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alphaD A Greenhalgh, X J Wang, L A Donehower, et al.
Molecular Carcinogenesis|January 1, 1989
Spontaneous Ha-ras gene activation in cultured primary murine keratinocytes: consequences of Ha-ras gene activation in malignant conversion and malignant progressionD A Greenhalgh, D J Welty, J E Strickland, et al.
Molecular Carcinogenesis|November 24, 1999
12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activationX J Wang, K M Liefer, D A Greenhalgh, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1995
12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomyD A Greenhalgh, X J Wang, J N Eckhardt, et al.
Nature Structural Biology|December 5, 2000
Patent protection for protein structures and databasesT C Meyers, T A Turano, D A Greenhalgh, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Molecular Carcinogenesis|June 13, 2024
14-3-3σ/Stratifin and p21 limit AKT-related malignant progression in skin carcinogenesis following MDM2-associated p53 lossCarol M McMenemy, Dajiang Guo, Jean A Quinn, et al.
The Journal of Biological Chemistry|September 25, 1993
Hydrophobic amino acids in the retinal-binding pocket of bacteriorhodopsinD A Greenhalgh, D L Farrens, S Subramaniam, et al.
Carcinogenesis|January 8, 2020
Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papillomaSiti F Masre, Nicola Rath, Michael F Olson, et al.
Oncogene|September 17, 2013
PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibitionF H Macdonald, D Yao, J A Quinn, et al.
Oncogene|December 20, 2016
ROCK2/ras<sup>Ha</sup> co-operation induces malignant conversion via p53 loss, elevated NF-κB and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-κB-mediated progressionS F Masre, N Rath, M F Olson, et al.
Cancer Research|October 1, 1996
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alphaD A Greenhalgh, X J Wang, L A Donehower, et al.
Molecular Carcinogenesis|January 1, 1989
Spontaneous Ha-ras gene activation in cultured primary murine keratinocytes: consequences of Ha-ras gene activation in malignant conversion and malignant progressionD A Greenhalgh, D J Welty, J E Strickland, et al.
Molecular Carcinogenesis|November 24, 1999
12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activationX J Wang, K M Liefer, D A Greenhalgh, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1995
12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomyD A Greenhalgh, X J Wang, J N Eckhardt, et al.
Nature Structural Biology|December 5, 2000
Patent protection for protein structures and databasesT C Meyers, T A Turano, D A Greenhalgh, et al.
Pageof 10